Tag: Biologics License Application

April 6, 2017

Theratechnologies Posts Financial Results For Q1 2017

Theratechnologies released their financial results for the first quarter of 2017.
April 5, 2017

Prometic Finishes FDA Filing

Prometic Life Sciences completed an FDA filing for their plasminogen biologics license application to treat patients with plasminogen congenital deficiency.
March 31, 2017

Prometic Posts 2016 Financial Results

Prometic Life Sciences (TSX:PLI, OTCQX:PFSCF) released their financial result for 2016 and its fourth quarter.